A204 Cells
545,10 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | A204 cells are human epithelial cells derived from the muscles of a 1-year-old female patient with rhabdomyosarcoma. With applications in 3D cell culture and tumorigenic properties, A-204 cells provide an opportunity for studying tumour biology and potential therapeutic interventions. Derived from muscle tissue, A-204 cells closely resemble the outer layer of cells found in organs and tissues. The A204 cell line is characterized by its aggressive undifferentiated phenotype, making it a valuable model for investigating the molecular mechanisms of tumorigenesis and metastasis in soft tissue sarcomas. The presence of specific isoenzymes, including AK-1, ES-D, G6PD, GLO-I, Me-2, PGM1, and PGM3, in A-204 cells provides insight into their metabolic characteristics. These isoenzymes may play a role in understanding cellular processes involved in cancer progression and treatment response. These cells exhibit robust growth in vitro and have been used to study cell proliferation, apoptosis, and drug resistance mechanisms. The A204 cell line is also instrumental in the evaluation of new chemotherapeutic agents and in understanding the interaction between rhabdomyosarcoma cells and therapeutic compounds. This cell line serves as an essential tool for cancer researchers aiming to develop more effective treatments for sarcomas and other related malignancies. |
|---|---|
| Organisme | Human |
| Tissu | Muscle |
| Maladie | Rhabdomyosarcoma |
| Site métastatique | Primary tumor site (muscle) |
| Applications | Rhabdomyosarcoma research; pediatric sarcoma biology; muscle differentiation studies; drug sensitivity; preclinical sarcoma models |
| Synonymes | A-204 |
Caractéristiques
| Âge | 1 year |
|---|---|
| Genre | Female |
| Morphologie | Epithelial-like |
| Type de cellule | Rhabdomyosarcoma cells |
| Propriétés de croissance | Adherent |
Données réglementaires
| Référence | A204 (Cytion catalog number 300109) |
|---|---|
| Niveau de biosécurité | 1 |
| NCBI_Numéro d'identification fiscale | 9606 |
| Cellosaurus - Numéro d'enregistrement | CVCL_1058 |
| Statut OGM | No genetic modification; wildtype rhabdomyosarcoma cell line |
Données biomoléculaires
| Isoenzymes | PGM3, 1, PGM1, 1, ES-D, 1, Me-2, 1, AK-1, 1, GLO-1, 1, G6PD, B |
|---|---|
| Tumorigène | In nude mice. Forms small malignant tumors which are conform to embryonal rhabdomyosarcoma. |
| Statut de ploïdie | Diploid and tetraploid |
| État du MSI | Stable (MSS) |
Manipulation
| Milieu de culture | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Suppléments | Supplement the medium with 10% FBS |
| Réactif de dissociation | Accutase |
| Temps de doublement | 26 to 36 hours |
| Repiquage | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Rapport de fractionnement | 1 to 5 |
| Densité de semis | 0.5 to 1 x 104 cells/cm2 |
| Renouvellement des fluides | 2 to 3 times per week |
| Rétablissement après le dégel | After thawing, plate the cells at 2 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 to 48 hours. |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificat d'analyse (CoA)
| Numéro de lot | Type de certificat | Date | Numéro de catalogue |
|---|---|---|---|
| 300109-920 | Certificat d'analyse | 15. Apr. 2025 | 300109 |
| 300109-270326 | Certificat d'analyse | 15. May. 2026 | 300109 |